Search Results for 'vagus nerve stimulation'
-
Study: Vagus Nerve Stimulation Reduces Inflammation in Children With IBD
Results from a proof-of-concept clinical trial show that ta-VNS led to remission in half of pediatric Crohn's disease patients.Michael Barbella, Managing Editor 01.10.24
-
Neurological
Tivic Health Initiates Bioelectronic Vagus Nerve Stimulation Study
20 individuals will undergo a new vagus nerve stimulation approach.Sam Brusco, Associate Editor 08.16.23
-
Tivic Health Systems Files Patent Application for Non-Invasive Vagus Nerve Stimulation Tech
Company's prior patents and current products have focused on the trigeminal and sympathetic nerve structures.Michael Barbella, Managing Editor 06.06.23
-
Neurological
Tivic Health Files Patent for Noninvasive Vagus Nerve Stimulation
The patent includes a novel circuit design to more precisely target the signals carried by the vagus nerve.Sam Brusco, Associate Editor 04.11.23
-
University of Minnesota Awarded $21M to Lead Vagus Nerve Stimulation Research
Funding will support the study of anatomical connections and functional effects of vagus nerve stimulation.Michael Barbella, Managing Editor 12.13.22
-
Neurological
FDA OKs electroCore's gammaCore to Prevent Migraines
Non-invasive vagus nerve stimulation therapy now available for migraine prevention and acute treatment.GlobeNewswire 03.30.20
-
Neurological
LivaNova's Symmetry VNS Therapy Gains CE Mark for Difficult-to-Treat Depression
Symmetry sends mild electric pulses to the vagus nerve, which is connected to areas of the brain that control mood.Business Wire 03.09.20
-
Contract Manufacturing | Electronics | Neurological
Taking Charge of an Illness with Neurostim Technology
An interview with Heraeus Medical Components' director of product development Steven Scott examining targeted nerve stimulation technologies.Online Exclusives Sam Brusco, Associate Editor 09.11.19
-
Contract Manufacturing | Electronics | Neurological
Shock to the System: An Examination of Neurostim Technologies
Targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.Sam Brusco, Associate Editor 09.09.19
-
electroCore Appoints Multiple Industry Veterans to Key Management Positions
Company welcomes new chief medical officer and chief financial officer.Globe Newswire 04.22.19
-
Cardiovascular
LivaNova Launches International Study Evaluating Use of Autonomic Regulation Therapy
Trial is designed to evaluate the therapy's efficacy as a heart failure treatment.Business Wire 10.22.18
-
LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77K Per Patient Over Five Years
Analysis finds overall cost savings far exceed system-related costs.Business Wire 10.09.18
-
LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment
Registry is evalulating the treatment for drug-resistant epilepsy.Business Wire 09.25.18
-
LivaNova Receives CE Mark for VNS Therapy SenTiva Generator
Company also granted European approval for next-generation programming system for epilepsy treatment.Business Wire 05.18.18
-
LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System
First patient enrolled at Rush University Medical Center in Illinois.Business Wire 05.02.18
-
Neurological
FDA Clears gammaCore Vagus Nerve Stimulation Therapy for Migraine-Associated Pain
First non-invasive vagus nerve stimulation therapy applied at neck provides new option for Americans living with migraine.PR Newswire 01.29.18
-
LivaNova Receives FDA Approvals for SenTiva Device, Next-Generation VNS Therapy Programming System
Products designed for epilepsy treatment.Business Wire 10.30.17
-
Neurological
LivaNova's Latest VNS Therapy System for Epilepsy Wins FDA Nod
Vagus Nerve Stimulation (VNS) Therapy offers patients with drug-resistant epilepsy a physician-directed customizable therapy.Videos Business Wire
-
Publicis Health CEO Joins electroCore’s Board of Directors
Nick Colucci brings healthcare communications expertise to enhance electroCore’s continued growth.electroCore 09.07.17
-
Neurological
FDA Releases electroCore's Neurostimulator for Episodic Cluster Headache
gammaCore is the first non-invasive vagus nerve stimulation therapy applied at the neck for acute treatment of pain.PR Newswire 04.18.17
-
Contract Manufacturing | Electronics | Materials | R&D & Design | Software & IT
Bridging the Digital Divide
EMS providers with DFM expertise and service flexibility are best suited to help their medtech partners achieve success.Michael Barbella, Managing Editor 01.30.17
-
electroCore Reorganizes its Management Team
Former COO becomes chief executive as founder assumes chief science and strategy officer position.electroCore LLC 07.26.16
-
Contract Manufacturing
EndoStim Names New President and CEO
Former chief executive to remain with company as a consultant.EndoStim Inc. 05.26.16
-
Clinical Trial for Migraine Prevention Device
Following success in cluster headache, electroCore is enrolling patients for two double blind migraine studies.electroCore 02.18.16
-
Device Significantly Exceeds Pharmaceuticals in Migraine Treatment
Vagus nerve stimulation suppresses cortical spreading depression—a trigger for migraine.electroCore 01.11.16
